Establishment Labs Holdings (ESTA) Change in Accured Expenses (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Change in Accured Expenses came in at $3.3 million in Q1 2026, down 17.26% year-on-year from $4.0 million in Q1 2025, and down 1.71% quarter-over-quarter from $3.4 million in Q4 2025.
Establishment Labs Holdings (ESTA) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 17.26% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 52.46% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, up 50.53% from the prior year.
- Change in Accured Expenses fell to $3.3 million in Q1 2026 per ESTA's latest filing, from $3.4 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $4.0 million in Q1 2025 and bottomed at -$3.4 million in Q2 2025.
- The 5-year median for Change in Accured Expenses is $49000.0 (2023), against an average of $389941.2.
- Biggest YoY gain for Change in Accured Expenses was 12836.36% in 2024; the steepest drop was 4930.51% in 2024.
- Year by year, Change in Accured Expenses stood at $274000.0 in 2022, then sank by 112.04% to -$33000.0 in 2023, then jumped by 5239.39% to $1.7 million in 2024, then soared by 100.41% to $3.4 million in 2025, then decreased by 1.71% to $3.3 million in 2026.
- Per Business Quant, the three latest ESTA Change in Accured Expenses figures stand at $3.3 million (Q1 2026), $3.4 million (Q4 2025), and -$2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.34 Mn |
| Mar 31, 2026 | 3.34 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Jun 30, 2025 | -3.39 Mn |
| Jun 30, 2025 | -3.39 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | -465,000.00 |
| Sep 30, 2024 | -465,000.00 |
| Jun 30, 2024 | -2.85 Mn |
| Jun 30, 2024 | -2.85 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Mar 31, 2024 | 2.85 Mn |
| Dec 31, 2023 | -33,000.00 |
| Dec 31, 2023 | -33,000.00 |